A jury in Chicago on Thursday rejected an Illinois ... evidence that Zantac does not cause cancer, and that they would vigorously defend themselves against future claims. Britain-based GSK ...

A woman who claimed in a lawsuit that GSK’s discontinued heartburn drug Zantac caused ... when another judge rejected about 50,000 lawsuits making similar claims that had been consolidated ...

"Judge Medinilla resoundingly rejected GSK ... introducing expert testimony that Zantac can cause cancer, as a federal judge did in 2022 in about 50,000 claims centralized in Florida.

won a defense verdict from state court jurors who rejected a claim that the discontinued heartburn drug Zantac caused an Illinois woman's colon cancer. The defense verdict comes more than two ...

saying the science behind the cancer claims was flawed. US District Judge Robin Rosenberg’s ruling also covered about 50,000 unfiled Zantac cases gathered before her for pretrial information ...

If the state high court rejects the appeal, the Zantac lawsuits will ... that Zantac could cause cancer, as a federal judge did in 2022 for about 50,000 claims in Florida. These lawsuits depend ...

The crux of her argument and the claims made in the other suits is that the active ingredient in Zantac, called ranitidine, degrades into the cancer-causing substance NDMA, or nitrosodimethylamine.

Hung jury in latest Zantac cancer trial in Chicago Boehringer Ingelheim only defendant after settlements with GSK, Pfizer FDA pulled Zantac in 2020 over NDMA carcinogen concerns Sept 18 (Reuters ...

Companies facing federal litigation, including Pfizer, gained a huge win in 2022 when a Florida district judge rejected the science backing the claims that Zantac can cause cancer. The ruling ...

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Although GSK has consented to the settlement, the firm has rejected any admission of guilt, citing an absence of "consistent or reliable evidence" connecting Zantac to cancer. Additionally ...

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion ... its heartburn drug Zantac caused cancer. The company said it ...